Z-2656-2017 Class II Terminated
FDA device recall Z-2656-2017 was initiated by JAS Diagnostics Inc. on Apr 21, 2017 and is designated Class II. Reason for recall: May result in elevated platelet backgrounds during routine startup/background checks. The recall status is terminated (terminated Jan 6, 2020). Affected quantity: 14,064.
Recall details
- Product Type
- Devices
- Report Date
- Jul 12, 2017
- Initiation Date
- Apr 21, 2017
- Termination Date
- Jan 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,064
Product description
Reason for recall
Distribution pattern
AL, AR, CA, FL, GA, IA, IN, LA, MA, MN, MO, NC, NE, NY, SC, TN, TX, and Puerto Rico United Arab Emirates, Bolivia, Republic of C¿te dIvoire, Colombia, Costa Rica, Ecuador, Egypt, Indonesia, Iraq, Italy, Korea, Mexico, Russia, Philippines, Slovenia, Tunisia, Venezuela, and Vietnam
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2656-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for JAS Diagnostics Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.